Inozyme Pharma (INZY) Stock Chart & Stock Price History $1.25 -0.02 (-1.18%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.26 +0.01 (+0.80%) As of 02/21/2025 04:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Inozyme Pharma Stock Price Performance 5 Day Performance-8.39%1 Month Performance-3.46%3 Month Performance-55.34%6 Month Performance-75.44%Year-To-Date Performance-54.69%1 Year Performance-77.35% Receive INZY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inozyme Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address INZY Stock Chart for Saturday, February, 22, 2025 INZY Chart by TradingView Inozyme Pharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$1.27$1.26-1.18%$1.31$1.25705,241 shs$80.62 million02/20/2025$1.31$1.27-3.05%$1.32$1.26663,272 shs$81.59 million02/19/2025$1.32$1.31-0.76%$1.35$1.31521,269 shs$84.15 million02/18/2025$1.37$1.32-3.65%$1.42$1.31583,032 shs$84.80 million02/17/2025$1.37$1.37$1.43$1.33425,996 shs$88.01 million02/14/2025$1.35$1.37+1.48%$1.43$1.33425,996 shs$88.01 million02/13/2025$1.35$1.35$1.38$1.28549,074 shs$86.72 million02/12/2025$1.29$1.35+4.65%$1.37$1.24526,419 shs$86.72 million02/11/2025$1.40$1.29-7.86%$1.42$1.27715,682 shs$82.87 million02/10/2025$1.45$1.40-3.45%$1.49$1.37697,941 shs$89.94 million Get the Latest News and Ratings for INZY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inozyme Pharma and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$1.50$1.45-3.33%$1.52$1.44405,167 shs$93.15 million02/06/2025$1.52$1.50-1.32%$1.56$1.47338,589 shs$96.36 million02/05/2025$1.36$1.52+11.76%$1.53$1.36837,877 shs$97.65 million02/04/2025$1.38$1.36-1.45%$1.45$1.36379,611 shs$87.37 million02/03/2025$1.44$1.38-4.17%$1.43$1.35786,673 shs$88.65 million01/31/2025$1.46$1.44-1.37%$1.62$1.42934,508 shs$92.51 million01/30/2025$1.42$1.46+2.82%$1.56$1.42786,858 shs$93.79 million01/29/2025$1.52$1.42-6.58%$1.57$1.40893,874 shs$91.22 million01/28/2025$1.36$1.52+11.76%$1.54$1.351.05 million shs$97.65 million01/27/2025$1.41$1.36-3.55%$1.44$1.34790,846 shs$87.37 million01/24/2025$1.32$1.41+6.82%$1.49$1.32911,758 shs$90.58 million01/23/2025$1.30$1.32+1.54%$1.32$1.241.03 million shs$84.80 million01/22/2025$1.35$1.30-3.70%$1.39$1.29981,820 shs$83.51 million01/21/2025$1.36$1.35-0.74%$1.44$1.331.40 million shs$86.72 million Related Companies Tourmaline Bio Stock Price Chart MBX Biosciences Stock Price Chart Cryoport Stock Price Chart Corvus Pharmaceuticals Stock Price Chart Prime Medicine Stock Price Chart Monopar Therapeutics Stock Price Chart Atyr PHARMA Stock Price Chart Trevi Therapeutics Stock Price Chart Allogene Therapeutics Stock Price Chart COMPASS Pathways Stock Price Chart Receive INZY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inozyme Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INZY) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inozyme Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inozyme Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
